INFLUENCE OF CYP2B6*6 GENOTYPE ON BUPROPION ENANTIOMERS METABOLISM AND CLEARANCE

被引:0
|
作者
Kharasch, E. D. [1 ]
Crafford, A. [1 ]
Parchomski, J. [1 ]
Blood, J. [1 ]
Regina, K. [1 ]
机构
[1] Washington Univ, St Louis, MO USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S54 / S54
页数:1
相关论文
共 50 条
  • [31] Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady state
    Benowitz, Neal L.
    Zhu, Andy Z. X.
    Tyndale, Rachel F.
    Dempsey, Delia
    Jacob, Peyton, III
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (03): : 135 - 141
  • [32] Hepatic CYP2B6 expression:: Gender and ethnic differences and relationship to CYP2B6 genotype and CAR (Constitutive Androstane Receptor) expression
    Lamba, V
    Lamba, J
    Yasuda, K
    Strom, S
    Davila, J
    Hancock, ML
    Fackenthal, JD
    Rogan, PK
    Ring, B
    Wrighton, SA
    Schuetz, EG
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (03): : 906 - 922
  • [33] CYP2B6, CYP2D6, and CYP3A4 catalyze the primary oxidative metabolism of perhexiline enantiomers by human liver microsomes
    Davies, Benjamin J.
    Coller, Janet K.
    Somogyi, Andrew A.
    Milne, Robert W.
    Sallustio, Benedetta C.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (01) : 128 - 138
  • [34] Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane
    D'Avolio, Antonio
    De Francia, Silvia
    Basile, Vittoria
    Cusato, Jessica
    De Martino, Francesca
    Pirro, Elisa
    Piccione, Francesca
    Ardito, Arianna
    Zaggia, Barbara
    Volante, Marco
    Di Perri, Giovanni
    Terzolo, Massimo
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (06): : 293 - 300
  • [35] Role of CYP2B6 in stereoselective human methadone metabolism
    Totah, Rheem A.
    Sheffels, Pamela
    Roberts, Toni
    Whittington, Dale
    Thummel, Kenneth
    Kharasch, Evan D.
    ANESTHESIOLOGY, 2008, 108 (03) : 363 - 374
  • [36] CYP2B6 Polymorphisms Influence the Plasma Concentration and Clearance of the Methadone S-Enantiomer
    Wang, Sheng-Chang
    Ho, Ing-Kang
    Tsou, Hsiao-Hui
    Tian, Jia-Ni
    Hsiao, Chin-Fu
    Chen, Chia-Hui
    Tan, Happy Kuy-Lok
    Lin, Linen
    Wu, Chi-Shin
    Su, Lien-Wen
    Huang, Chieh-Liang
    Yang, Yi-Hong
    Liu, Ming-Lun
    Lin, Keh-Ming
    Chen, Chun-Yu
    Liu, Shu Chih
    Wu, Hsiao-Yu
    Chan, Hsiu-Wen
    Tsai, Ming-Hsien
    Lin, Pei-Sheng
    Liu, Yu-Li
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (04) : 463 - 469
  • [37] Stereoselectivity in metabolism of ifosfamide by CYP3A4 and CYP2B6
    Lu, H.
    Wang, J. J.
    Chan, K. K.
    Philip, P. A.
    XENOBIOTICA, 2006, 36 (05) : 367 - 385
  • [38] CYP2B6 and Bupropion's Smoking-Cessation Pharmacology: The Role of Hydroxybupropion
    Zhu, A. Z. X.
    Cox, L. S.
    Nollen, N.
    Faseru, B.
    Okuyemi, K. S.
    Ahluwalia, J. S.
    Benowitz, N. L.
    Tyndale, R. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (06) : 771 - 777
  • [39] Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism
    Ring, Huijun Z.
    Valdes, Ana M.
    Nishita, Denise M.
    Prasad, Suman
    Jacob, Peyton, III
    Tyndale, Rachel F.
    Swan, Gary E.
    Benowitz, Neal L.
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (12): : 1007 - 1015
  • [40] CYP2B6 poor metaboliser alleles involved in efavirenz and nevirapine metabolism: CYP2B6*9 and CYP2B6*18 distribution in HIV-exposed subjects from Dschang, Western Cameroon
    Paganotti, Giacomo Maria
    Russo, Gianluca
    Sobze, Martin Sanou
    Mayaka, George Bouting
    Muthoga, Charles Waithaka
    Tawe, Leabaneng
    Martinelli, Axel
    Romano, Rita
    Vullo, Vincenzo
    INFECTION GENETICS AND EVOLUTION, 2015, 35 : 122 - 126